With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena

cafead

Administrator
Staff member
  • cafead   Jan 23, 2023 at 11:02: AM
via A little over a month after bexagliflozin’s approval to treat cats with diabetes, the drug has been cleared in humans.

article source
 

<